BioPharm Update: Dynavax Technologies Corporation
Post# of 23098
(Total Views: 273)
Posted On: 07/28/2017 8:15:01 PM
BioPharm Update:
Dynavax Technologies Corporation (NASDAQ: DVAX) shares are currently trading up 82% to $16.85 following news that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 12 to 1 that the safety data for HEPLISAV-B support approval for the immunization against Hepatitis B infection in adults 18 years of age and older. Three members of the panel abstained. The PDUFA date for the final approval decision is set for August 10, 2017.
Tenax Therapeutics, Inc. (NASDAQ: TENX) announced that the FDA has requested the company conduct an additional trial for its pipeline candidate levosimendan. Its previous Phase 3 trial in January 2017, did not meet the primary endpoint. Shares have slumped in the after-hours session, currently trading down 27% to $0.50. Tenax noted in Friday’s release that “given the size and scope of such a trial, the Company is reviewing clinical, regulatory and financial options with regard to the levosimendan program in the U.S. and Canada.”
Kamada Ltd. (NASDAQ:KMDA) shares slid to close down 13% to $4.50 following the pricing of its underwritten public offering of 3,333,334 shares at a price of $4.50 per share.
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) shares also slumped to close down 31% to $0.67 following the pricing of its offering of 21.5m shares and warrants to purchase 18.275m shares at an offering price of $0.75 per share and related warrant. The warrants have an exercise price of $1.05 per share.
Other Major price movers (stocks priced > $1.00, volume > 100k):
Refer to the BioPharmCatalyst Biotech Stocks page for Top 10 Gainers/Losers/Unusual Volume INCLUDING sub-$1 stocks.
ADVANCERS:
Novan Inc (NASDAQ:NOVN): $5.31; +25%.
22nd Century Group Inc (NYSEMKT:XXII): $1.75; +21%.
ImmunoGen, Inc. (NASDAQ:IMGN) $6.96; +14%.
Syros Pharmaceuticals Inc (NASDAQ:SYRS): $23.06; +13%.
Advanced Accelerator Application (ADR) (NASDAQ:AAAP): $47.20; +11%.
DECLINERS:
Capricor Therapeutics Inc (NASDAQ:CAPR): $1.14; -12%.
Regulus Therapeutics Inc (NASDAQ:RGLS): $1.02; -9%.
Cidara Therapeutics Inc (NASDAQ:CDTX): $7.30; -8%.
ADMA Biologics Inc (NASDAQ:ADMA): $3.37; -7%.
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH): $6.48;
Dynavax Technologies Corporation (NASDAQ: DVAX) shares are currently trading up 82% to $16.85 following news that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 12 to 1 that the safety data for HEPLISAV-B support approval for the immunization against Hepatitis B infection in adults 18 years of age and older. Three members of the panel abstained. The PDUFA date for the final approval decision is set for August 10, 2017.
Tenax Therapeutics, Inc. (NASDAQ: TENX) announced that the FDA has requested the company conduct an additional trial for its pipeline candidate levosimendan. Its previous Phase 3 trial in January 2017, did not meet the primary endpoint. Shares have slumped in the after-hours session, currently trading down 27% to $0.50. Tenax noted in Friday’s release that “given the size and scope of such a trial, the Company is reviewing clinical, regulatory and financial options with regard to the levosimendan program in the U.S. and Canada.”
Kamada Ltd. (NASDAQ:KMDA) shares slid to close down 13% to $4.50 following the pricing of its underwritten public offering of 3,333,334 shares at a price of $4.50 per share.
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) shares also slumped to close down 31% to $0.67 following the pricing of its offering of 21.5m shares and warrants to purchase 18.275m shares at an offering price of $0.75 per share and related warrant. The warrants have an exercise price of $1.05 per share.
Other Major price movers (stocks priced > $1.00, volume > 100k):
Refer to the BioPharmCatalyst Biotech Stocks page for Top 10 Gainers/Losers/Unusual Volume INCLUDING sub-$1 stocks.
ADVANCERS:
Novan Inc (NASDAQ:NOVN): $5.31; +25%.
22nd Century Group Inc (NYSEMKT:XXII): $1.75; +21%.
ImmunoGen, Inc. (NASDAQ:IMGN) $6.96; +14%.
Syros Pharmaceuticals Inc (NASDAQ:SYRS): $23.06; +13%.
Advanced Accelerator Application (ADR) (NASDAQ:AAAP): $47.20; +11%.
DECLINERS:
Capricor Therapeutics Inc (NASDAQ:CAPR): $1.14; -12%.
Regulus Therapeutics Inc (NASDAQ:RGLS): $1.02; -9%.
Cidara Therapeutics Inc (NASDAQ:CDTX): $7.30; -8%.
ADMA Biologics Inc (NASDAQ:ADMA): $3.37; -7%.
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH): $6.48;
(1)
(0)
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'
https://twitter.com/twitter/statuses/957208055766241280
https://twitter.com/twitter/statuses/957208055766241280